Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

44806 ARTÍCULOS , VIENDO DEL 871 AL 885

Validating automated speech timing methods in clinical and healthy speakers across sentence, paragraph, and monologue tasks

Arzbecker LJ, Tjaden K.

J Acoust Soc Am. 2026 Jun 1;159(6):5238-5257. doi: 10.1121/10.0044119.

Global prevalence and disability burden of brain disorders: Impact of neurological, mental, and substance use disorders

Salehinejad MA, Fathi Jouzdani A, Bandeira ID, Bender S, Bikson M, Castelo-Branco M, Cohen Kadosh R, Costanzo F, Croarkin PE, Desarkar P, Dyke K, Eickhoff S, Fitzgerald PB, Hartwigsen G, Koenig J, Martino D, Menghini D, Mirfazeli FS, Moliadze V, Nitsche MA, Oberman LM, Siniatchkin M, Vaziri Z, Vicario CM, Vöckel J, Wischnewski M, Wolters CH, Zangen A, Zaehle T, Zomorrodi R, Brunoni AR.

Neurosci Biobehav Rev. 2026 Sep;188:106808. doi: 10.1016/j.neubiorev.2026.106808. Epub 2026 Jun 10.

Dual-target gene therapy in Parkinson's disease: a multicenter phase 1 trial

Niu M, Guo J, Yang Y, Xu Q, Cheng C, Li H, Luo N, Zhou H, Zhang P, Li Y, Wang N, Wang C, Li D, Lin Z, Huang P, Yang Z, Yang Z, Song Y, Zheng J, Jiang W, Du Z, Qi Y, Peng H, Tan Y, Hu X, Xiao X, Shen L, Lin J, Liu J.

Nat Med. 2026 Jul;32(7):2602-2609. doi: 10.1038/s41591-026-04436-0. Epub 2026 Jun 10.

What can we learn from eye movements in movement disorders and Parkinson's disease?

Ravat P, Ghasia FF, Shaikh AG.

Curr Opin Neurol. 2026 Aug 1;39(4):415-422. doi: 10.1097/WCO.0000000000001501. Epub 2026 Jun 10.

α-Klotho as a central integrative signalling hub in cognitive function and neuroprotection in neurodegenerative diseases

Bindal P, Kuwar OK, Singh VK, Attri M, Pallavi, Tejpal S.

Metab Brain Dis. 2026 Jun 11;41(1):133. doi: 10.1007/s11011-026-01897-7.

Environmental Factors Drive Neurodegenerative Diseases Through Glutamate Excitotoxicity: A Convergent Mechanistic Pathway

He Y, Yi T, Min M, Xu K, Lin H, Xu R, Deng D, Xiao X.

Neurosci Bull. 2026 Jun 11. doi: 10.1007/s12264-026-01645-y. Online ahead of print.

The Role of Serotonergic System in Parkinson's Disease-Related Pain

Song YZ, Shen YQ.

Neurosci Bull. 2026 Jun 11. doi: 10.1007/s12264-026-01649-8. Online ahead of print.

State-of-the-Art Imaging and Localization Assessment in Post-Operative Deep Brain Stimulation for Parkinson's Disease: A Review

Susanto KT, Premchand B, Wan KR, Yu WY, Oh HP, Chan VEY, Misbaah F, So RQ.

Stereotact Funct Neurosurg. 2026 Jun 11:1-13. doi: 10.1159/000553009. Online ahead of print.

Is Parkinson's really a disease? Reframing it as a phenotype of aging

Dashtipour K.

Parkinsonism Relat Disord. 2026 Aug;149:108387. doi: 10.1016/j.parkreldis.2026.108387. Epub 2026 Jun 9.

A treadmill training program in a gamified virtual reality environment combined with transcranial direct current stimulation in Parkinson's Disease: Preliminary results of a mixed methods randomized controlled trial

Bosch-Barceló P, Tersa-Miralles C, Martínez-Navarro O, Masbernat-Almenara M, Pakarinen A, Fernández-Lago H.

Neurol Sci. 2026 Jun 12;47(7):564. doi: 10.1007/s10072-026-09136-8.

Stem Cell Therapy for Parkinson's Disease: A Mechanistically Distinct Role for Muse Cells

Mesches MH, Granholm AC, Paredes D, Mesches K, Oguma Y, Dezawa M.

J Clin Med. 2026 Jun 5;15(11):4370. doi: 10.3390/jcm15114370.

Herbal Neurotherapeutics for Cognitive Disorders: Integrative Mechanisms Linking Neurotransmitter Systems, Neurodegeneration, and the Gut-Brain Axis

Rahman M, Akter K, Rani A, Park MN, Kim B.

Nutrients. 2026 Jun 2;18(11):1796. doi: 10.3390/nu18111796.

The Role of the IL-33/ST2 Axis in Nervous System Development and Diseases

Luo Z, Yang J.

Immunol Cell Biol. 2026 Aug;104(7):671-681. doi: 10.1111/imcb.70138. Epub 2026 Jun 11.

A genome-wide association study of young onset Parkinson's disease in European ancestry

Lie IH, van Wetering J, Valori M, Brolin KA, Step K, Schulte C, Iwaki H, Bandres-Ciga S, Leonard H, Sharma M; International Parkinson’s Disease Genomics Consortium; Global Parkinson’s Genetics Program; Singleton A, Pihlstrøm L.

medRxiv [Preprint]. 2026 Jun 4:2026.06.03.26354799. doi: 10.64898/2026.06.03.26354799.

HFE genotype influences substantia nigra iron accumulation and Parkinson's disease progression

Du G, Wang E, Sica C, Stone R, De Jesus S, Kong L, Mailman RB, Huang X.

medRxiv [Preprint]. 2026 Jun 3:2026.06.02.26354750. doi: 10.64898/2026.06.02.26354750.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias